ETIGILIMAB

UNII:	FC1ZF28VIT
Formula:
Preferred Substance Name:	ETIGILIMAB
GSRS Full Record:	FC1ZF28VIT i

2044984-83-8
ETIGILIMAB [INN]
ETIGILIMAB [USAN]
ETIGILIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TIGIT(T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS)) (HUMANIZED MOUSE MONOCLONAL OMP-313M32 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL OMP-313M32 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS (V-SET AND IMMUNOGLOBULIN DOMAIN-CONTAINING PROTEIN 9)) HUMANIZED MONOCLONAL ANTIBODY .GAMMA.1 HEAVY CHAIN (1-448) (HOMO SAPIENS VH (IGHV4-38-2*01 (89%) (IGHD)-IGHJ4*01 (93%) (9.7.11) (1-118) -HOMO SAPIENS IGHG1*03) (119-448) (221-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV1-33*01 (85%) IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*05 (108'-214')), DIMER (227-227'':230-230'')-BISDISULFIDE)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ETIGILIMAB

Synonyms and Mappings

Resources